MX174129B - Procedimiento para la preparacion de nuevos 19-nor-esteroides sustituidos en la posicion 7 y producto obtenido - Google Patents

Procedimiento para la preparacion de nuevos 19-nor-esteroides sustituidos en la posicion 7 y producto obtenido

Info

Publication number
MX174129B
MX174129B MX010471A MX1047188A MX174129B MX 174129 B MX174129 B MX 174129B MX 010471 A MX010471 A MX 010471A MX 1047188 A MX1047188 A MX 1047188A MX 174129 B MX174129 B MX 174129B
Authority
MX
Mexico
Prior art keywords
group
carbon atoms
steroids
hydrogen
optionally substituted
Prior art date
Application number
MX010471A
Other languages
English (en)
Other versions
MX10471A (es
Inventor
Daniel Philibert
Francois Nique
Lucien Nedelec
Marie-Madeleine Bouton
Original Assignee
Roussel Uclaf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf filed Critical Roussel Uclaf
Publication of MX10471A publication Critical patent/MX10471A/es
Publication of MX174129B publication Critical patent/MX174129B/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J61/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by contraction of only one ring by one or two atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0066—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
    • C07J1/007—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/001—Lactones
    • C07J21/003—Lactones at position 17
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0044—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 with an estrane or gonane skeleton, including 18-substituted derivatives and derivatives where position 17-beta is substituted by a carbon atom not directly bonded to another carbon atom and not being part of an amide group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0072—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the A ring of the steroid being aromatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)

Abstract

La presente invención se refiere a los productos de la fórmula general I: en la cual el ciclo A representa una de las estructuras siguientes: a/. o A representa la agrupación; b/. o A representa la agrupación; en la cual Re representa un átomo de hidrógeno, un radical alquilo que tiene de 1 a 6 átomos de carbono eventualmente substituído o un radical acilo; R representa un radical metilo o etilo; R1 representa un radical hidroxilo eventualmente protegido o acilado o un radical alcoxilo; R2 representa un átomo de hidrógeno, un radical alquilo, alquenilo o alquinilo cuando mucho de 8 átomos de carbono o un radical arilo aralquilo cuando mucho de 15 átomos de carbono, estando eventualmente sustituído por alguno de los radicales alquilo, alquenilo, alquinilo, arilo o aralquilo o bien R1 y R2 forman, juntos, un radical seleccionado entre los radicales: Ar representa un radical arilo de 5 ó 6 eslabones, eventualmente sustituído; así como las sales de adición de los productos de la fórmula I con los ácidos y las bases.
MX010471A 1987-02-18 1988-02-18 Procedimiento para la preparacion de nuevos 19-nor-esteroides sustituidos en la posicion 7 y producto obtenido MX174129B (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8702072A FR2610933B1 (fr) 1987-02-18 1987-02-18 Nouveaux 19-nor steroides substitues en position 7, leur preparation, leur application comme medicaments, les compositions pharmaceutiques les renfermant

Publications (2)

Publication Number Publication Date
MX10471A MX10471A (es) 1993-09-01
MX174129B true MX174129B (es) 1994-04-22

Family

ID=9348042

Family Applications (1)

Application Number Title Priority Date Filing Date
MX010471A MX174129B (es) 1987-02-18 1988-02-18 Procedimiento para la preparacion de nuevos 19-nor-esteroides sustituidos en la posicion 7 y producto obtenido

Country Status (15)

Country Link
US (1) US4874754A (es)
EP (1) EP0280618B1 (es)
JP (1) JP2717792B2 (es)
KR (1) KR960007868B1 (es)
AT (1) ATE81133T1 (es)
AU (1) AU610560B2 (es)
CA (1) CA1313653C (es)
DE (1) DE3874909T2 (es)
ES (1) ES2043862T3 (es)
FI (1) FI92589C (es)
FR (1) FR2610933B1 (es)
GR (1) GR3006139T3 (es)
MX (1) MX174129B (es)
PT (1) PT86783B (es)
ZA (1) ZA881030B (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1212835B (it) * 1983-08-18 1989-11-30 Lehner Ag Derivati di acidi biliari, procedimento per la loro preparazione e relative composizioni farmaceutiche.
US5686465A (en) * 1988-10-31 1997-11-11 Endorecherche Inc. Sex steroid activity inhibitors
US5395842A (en) * 1988-10-31 1995-03-07 Endorecherche Inc. Anti-estrogenic compounds and compositions
US5204337A (en) * 1988-10-31 1993-04-20 Endorecherche Inc. Estrogen nucleus derivatives for use in inhibition of sex steroid activity
HU208150B (en) * 1988-10-31 1993-08-30 Endorecherche Inc Process for producing new estrogen derivatives having steroid hormone inhibitor activity and pharmaceutical compositions comprising such derivatives
US5364847A (en) * 1989-03-10 1994-11-15 Endorecherche Inhibitors of sex steroid biosynthesis and methods for their production and use
DE3921059A1 (de) * 1989-06-23 1991-01-10 Schering Ag 11(beta)-aryl-4-estrene, verfahren zu ihrer herstellung sowie deren verwendung als arzneimittel
ZA924811B (en) * 1991-06-28 1993-12-29 Endorecherche Inc Controlled release systems and low dose androgens
US6060503A (en) * 1991-12-02 2000-05-09 Endorecherche, Inc. Benzopyran-containing compounds and method for their use
JPH07101977A (ja) * 1993-10-05 1995-04-18 Kureha Chem Ind Co Ltd ホルモン作用を軽減した新規なエストラジオール誘導体及びその増殖因子阻害剤
WO1995018821A2 (en) * 1994-01-06 1995-07-13 Sri International Novel antiandrogenic agents and related pharmaceutical compositions and methods of use
US6355630B1 (en) 1997-10-23 2002-03-12 American Home Products Corporation Estra-1,3,5(10)-triene-7α-thioethers
CA2308773A1 (en) * 1997-10-23 1999-04-29 Ivo Jirkovsky Estra-1,3,5(10)-triene-7alpha-thioethers
US6020328A (en) * 1998-03-06 2000-02-01 Research Triangle Institute 20-keto-11β-arylsteroids and their derivatives having agonist or antagonist hormonal properties
US5962444A (en) * 1998-05-29 1999-10-05 Research Triangle Institute 17β-nitro-11β-arylsteroids and their derivatives having agonist or antagonist hormonal properties
US6262042B1 (en) 1998-05-29 2001-07-17 Research Triangle Institute 17β-amino and hydroxylamino-11β-arylsteroids and their derivatives having agonist or antagonist hormonal properties
MXPA04009178A (es) * 2002-03-22 2004-11-26 Upjohn Co Proceso para preparar eplerenona.
US7235655B2 (en) * 2002-03-22 2007-06-26 Pharmacia & Upjohn Company Processes to prepare eplerenone
PL356465A1 (en) * 2002-10-04 2004-04-05 ANPHARM Przedsiębiorstwo Farmaceutyczne S.A. METHOD OF MANUFACTURE OF 17beta-HYDROXY-7alpha-METHYL-19-NOR-17alpha-PREGN-5(10)-ENE-20-YNE-3-ONE
CA2813433C (en) 2010-10-27 2019-08-20 Dignity Health Trimegestone (tmg) for treatment of preterm birth

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2739974A (en) 1953-04-06 1956-03-27 Searle & Co Process of preparing delta4,6-3-ketosteroids
US3099664A (en) 1959-01-12 1963-07-30 Syntex Corp 7-cyano androstane compounds
US3673225A (en) * 1970-01-16 1972-06-27 Organon New 7-alkyl-steroids
FR2528434B1 (fr) * 1982-06-11 1985-07-19 Roussel Uclaf Nouveaux 19-nor steroides substitues en 11b et eventuellement en 2, leur procede de preparation et leur application comme medicament
FR2522328B1 (fr) * 1982-03-01 1986-02-14 Roussel Uclaf Nouveaux produits derives de la structure 3-ceto 4,9 19-nor steroides, leur procede de preparation et leur application comme medicaments
DE3427795A1 (de) * 1984-07-25 1986-02-06 Schering AG, 1000 Berlin und 4709 Bergkamen Neue 17(alpha)-halogenvinyl-estran-derivate, ihre herstellung und verwendung in der medizin

Also Published As

Publication number Publication date
KR880009987A (ko) 1988-10-06
DE3874909T2 (de) 1993-05-13
ES2043862T3 (es) 1994-01-01
EP0280618A1 (fr) 1988-08-31
CA1313653C (fr) 1993-02-16
FI880742A0 (fi) 1988-02-17
FI92589C (fi) 1994-12-12
JPS63222198A (ja) 1988-09-16
ATE81133T1 (de) 1992-10-15
GR3006139T3 (es) 1993-06-21
FR2610933A1 (fr) 1988-08-19
PT86783B (pt) 1992-05-29
DE3874909D1 (de) 1992-11-05
MX10471A (es) 1993-09-01
KR960007868B1 (ko) 1996-06-13
FI92589B (fi) 1994-08-31
FR2610933B1 (fr) 1989-06-09
JP2717792B2 (ja) 1998-02-25
AU610560B2 (en) 1991-05-23
AU1178588A (en) 1988-08-25
EP0280618B1 (fr) 1992-09-30
FI880742A (fi) 1988-08-19
PT86783A (pt) 1988-03-01
US4874754A (en) 1989-10-17
ZA881030B (en) 1989-04-26

Similar Documents

Publication Publication Date Title
MX174129B (es) Procedimiento para la preparacion de nuevos 19-nor-esteroides sustituidos en la posicion 7 y producto obtenido
ATE102193T1 (de) Thiazolidinedionederivate.
ES2066875T3 (es) Aminoalquilindoles, procedimiento para su obtencion y preparados farmaceuticos que los contienen.
SE7711168L (sv) Nya 1-aryloxi-2-hydroxi-3-alkylenaminopropaner och forfarande for deras framstellning
ES469953A1 (es) Un procedimiento para la preparacion de nuevos derivados de aminoalquilbenceno
DE3069813D1 (en) Pharmaceutical composition containing a diphenylhydantoin derivative, derivatives used and their preparation
ES523658A0 (es) Procedimiento para la obtencion de azolil-cetonas y -alcoholes sustituidos.
PT87275A (pt) Process for the preparation of a repugnant composition of insects and acarids containing a substituted by product of alpha omega-aminoalcohols and of certains alpha omega-aminoalcohols replaced
AU601687B2 (en) New derivatives of carboxamide indole, their salts, process and intermediates for preparation, use as medicaments and compositions containing them
ES524990A0 (es) Procedimiento para preparar derivados de tieno-tiazol
KR890009901A (ko) 3-히드록시-2-(4-메톡시페닐)-5-(2-메틸아미노에틸)-2,3-디히드로-5h-1,5- 벤조티아제핀-4-온 유도체, 그의 제조 및 치료에의 이용
MX9633A (es) Procedimiento para la preparacion de nuevos productos esteroides que llevan en la posicion 23 un radical sulfinilo y producto obtenido.
AU4995690A (en) New 1-arylsulphonyl-2-piperidin-one derivatives, process and intermediates for the preparation thereof, their application as medicinal products and compositions containing them
FI890187A0 (fi) Foerfarande foer framstaellning av hydroxialkylerande foereningar, saolunda erhaollna nya foereningar och deras anvaendning.
IL102541A0 (en) Pharmaceutical antihypertensive combination preparations
DE3874920D1 (de) Benzimidazol-2-one-derivate, deren salze, verfahren und zwischenprodukte zu deren herstellung, deren anwendung als arzneimittel und sie enthaltende zusammensetzungen.
MX11976A (es) Procedimiento para preparar derivados de 1-benzoil-2-oxo-5-alcoxi-pirrolidina y producto obtenido.
KR850000454A (ko) 세팔로스포린 유도체의 제조방법
SE8302452D0 (sv) Method for treatment of senile dementia
AU6466890A (en) New derivatives substituted in position 15 of 20,21-dinoreburnamenine, their preparation process and the new intermediates thus obtained, their use as medicaments and the compositions containing them
ES531141A0 (es) Un procedimiento para preparar derivados de tropona
SE7901034L (sv) Nya anilider med antitussiv verkan och forfarande for framstellning derav
KR890700573A (ko) 3-치환된-1-알킬아미노-2-프로판올의 불안정한 케톤유도체 및 β -아드레날린 저지제로서 이들의 용도
SE7905025L (sv) Tereftalsyramonoamidderivat, forfarande for framstellning derav och antiallergiskt medel
SE7704584L (sv) Forfarande for framstellning av nya morfolinderivat